IDSA Guidelines on the Treatment and Management of Patients with COVID-19 – Infectious Diseases Society of America Related: [Preprint] RCT: In symptomatic adults above 18 years positive for SARS-CoV-2, early outpatient treatment with high-titer convalescent plasma significantly reduced hospitalizations.   Commentary on Twitter Update Alert: Revised recommendation on the use of #convalescentplasma in ambulatory patients […]

The post IDSA Updated Covid-19 Guideline now supports the use of convalescent plasma in ambulatory patients with mild to moderate COVID-19 at high risk for progression to severe disease. appeared first on Links Medicus.